Skip to main content
Premium Trial:

Request an Annual Quote

BioTrove Names imaGenes OpenArray Service Provider

NEW YORK (GenomeWeb News) – BioTrove has named imaGenes as an OpenArray Service Provider, the first such designation for a firm outside of the US, imaGenes said today.

The Berlin-based genomics services provider will offer applications such as gene expression profiling, microRNA profiling analyses, and biomarker studies on the real-time qPCR platform. The OpenArray can run 9,000 assays simultaneously and enables one person to generate more than 27,000 assays in a single day.

"We chose imaGenes for their extensive experience in microarray and next generation sequencing services," Derek Potter, BioTrove's european director, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.